Experts say it’s often called childhood Alzheimer’s because the symptoms are similar and it mostly impacts the brain. “It was difficult when we got the diagnosis, you are told your child is basically ...
AAV gene therapy as a treatment for patients with Sanfilippo syndrome type A (MPS IIIA). “The path to get a treatment to the point of a BLA filing has been long and perilous for the Sanfilippo ...
It was revealed that Clark had Sanfilippo syndrome, a rare disease that is often described as childhood Alzheimers. "In my mind, I'm sitting there thinking, like, I'm not going to watch him grow ...
Sanfilippo Syndrome Type A, or MPS IIIA, is a rare, fatal neurodegenerative disease in which the body is unable to break down a complex sugar molecule called heparan sulfate. This disorder ...
Ultragenyx Pharmaceutical RARE announced that it has submitted a biologics license application (BLA) to the FDA for its UX111 (ABO-102) AAV gene therapy as a treatment for patients with Sanfilippo ...
About UX111 UX111 is a novel in vivo gene therapy in Phase 1/2/3 development for Sanfilippo syndrome type A (MPS IIIA), a rare fatal lysosomal storage disease with no approved treatment that ...
Clark Willmore was recently diagnosed with Sanfilippo syndrome, a degenerative disease that causes similar symptoms to Alzheimer's but in children. James Dean, a lifelong Vol fan, saw a post on ...